FCGR2A and Autoimmunity: On the other end, a relatively more active immune response, conferred by FCGR2A-p.166His, is associated with the development of ITP, Kawasaki disease and inflammatory bowel disease, emphasizing the intricate role of FCGR2A at the interface of multiple pathways leading to autoimmunity.